Improving genetic health care: A northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 151, Issue 3, 2009, Pages 241-254

  Moeschler, John B ^a,b,g   Amato, R Stephen ^c   Brewster, Thomas ^d   Burke, Leah ^e,f   Dinulos, Mary Beth ^g   Smith, Rosemarie ^e,h   Smith, Wendy ^e,h   Miller, Patrick ⁱ  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

^d Barbara Bush Children's Hospital   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f Vermont Regional Genetics Center   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^h MAINE MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

Array CGH; Global developmental delay; Intellectual disability; Quality improvement

Indexed keywords

ARTICLE; CHILD; CLINICAL GENETICS; CLINICAL PRACTICE; COMPARATIVE GENOMIC HYBRIDIZATION; CYSTIC FIBROSIS; DEVELOPMENTAL DISORDER; GENE DELETION; GENETIC ANALYSIS; HEALTH CARE DELIVERY; HEALTH CARE PRACTICE; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; INTELLECTUAL IMPAIRMENT; MEDICAL SOCIETY; METHODOLOGY; OUTCOME ASSESSMENT; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; WILLIAMS BEUREN SYNDROME;

CHILD; DELIVERY OF HEALTH CARE; DEVELOPMENTAL DISABILITIES; FEMALE; GENETIC SCREENING; GENETIC SERVICES; HUMANS; KARYOTYPING; MALE; MENTAL RETARDATION; NEW ENGLAND; NUCLEIC ACID HYBRIDIZATION; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 67651242061     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30221     Document Type: Article

References (42)

1. Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, Stevenson R, Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. 2003. Practice parameter: Evaluation of the child with global developmental delay - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 60:367-380.
2. Batalden P. 2009. www.dartmouth.edu/∼cecs/ hcild/hcild.html (last accessed June 24, 2009).
3. Batalden PB, Davidoff F. 2007. What is "quality improvement" and how can it transform health care? Qual Saf Health Care 16: 2-3.
4. Batalden P, Berwick D, Bisognano M, Splaine M, Baker G, Headrick L. 1998. Knowledge domains for health professional students seeking competency in the continual improvement and innovation of health care. Boston, MA: Institute for Healthcare Improvement.
5. Batalden P, Nelson EC, Gardent PB, Godfrey MM. 2005. Leading the macrosystem and mesosystem for microsystem peak performance. From Front Office to Front Line: Essentials Issues for Health Care Leaders, Joint Commission Resources, Oakbrook Terrace, IL.
6. Baylor College of Medicine Medical Genetics Laboratories. 2009. Baylor College of Medicine Medical Genetics Laboratories, Houston, TX. www.bcm.edu/geneticlabs/ last (accessed May 29, 2009).
7. Ben-Shachar S, Ou Z, Shaw CA, Belmont JW, Patel MS, Hummel M, Amato S, Tartaglia N, Berg J, Sutton VR, Lalani SR, Chinault AC, Cheung SW, Lupski JR, Patel A. 2008. 22q11.2 distal deletion: A recurrent genomic disorder distinct from Di George syndrome and velocardiofacial syndrome. Am J Hum Genet 82:214-221.
8. Berwick DM. 2002. A user's manual for the IOM's "Quality Chasm" report. Health Affairs 21:80-90.
9. BiW, Sapir T, Shchelochkov O, Zhang F, Withers MA, Hunter JV, Levy T, Shinder V, Peiffer DA, Gunderson KL, Nezarati MM, Shotts VA, Amato RSS, Savage SK, Harris DJ, Day-Salvatore D-L, Horner M, Lu X-Y, Sahoo T, Yanagawa Y, Beaud AL, Cheung SW, Martinez S, Lupski JR, Reiner O. 2009. Increased LIS1 expression affects human and mouse brain development. Nat Genet 41:168-177.
10. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, Lalani SR, Graham B, Lee B, Shinawi M, Shen J, Kang SH, Pursley A, Lotze T, Kennedy G, Lansky-Shafer S, Weaver C, Roeder ER, Grebe TA, Arnold GL, Hutchison T, Reimschisel T, Amato S, Geragthy MT, Innis JW, Obersztyn E, Nowakowska B, Rosengren SS, Bader PI, Grange DK, Naqvi S, Garnica AD, Bernes SM, Fong CT, Summers A, Walters WD, Lupski JR, Stankiewicz P, Cheung SW, Patel A. 2008. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40:1466-1471.
11. Campbell H, Bradshaw N, Davidson R, Dean J, Goudie D, Holloway S, Porteous M. 2000. Evidence based medicine in practice: Lessons from a Scottish clinical genetics project. J Med Genet 37:684-691.
12. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JMJr, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J. 1997. Evaluation of mental retardation: Recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 72:468-477.
13. Davis DA, Thomson MA, Oxman AD, Haynes RB. 1995. Changing physician performance: A systematic review of the effect of continuing medical education strategies. J Am Med Assoc 274:700-705.
14. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. 1999. Impact of formal continuing medical education: Do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? J Am Med Assoc 282:867-874.
15. Davis D, Evans M, Jadad A, Perrier L, Rath D, Ryan D, Sibbald G, Straus S, Rappolt S, Wowk M, Zwarenstein M. 2003. The case for knowledge translation: Shortening the journey from evidence to effect. Br Med J 327:33-35.
16. GeneDx. 2009. Gaithersburg, MD. http://genedx. com/ (last accessed May 29, 2009).
17. Horbar JD, Rogowski J, Plsek PE, Delmore P, Edwards WH, Hocker J. 2001. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 107:4-22.
18. Horbar JD, Carpenter JH, Buzas J, Soll RF, Suresh G, Bracken MB, Leviton LC, Plsek PE, Sinclair JC. 2004. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: Is routine practice evidence based? Pediatrics 113:1593-1602.
19. Hunter AG, 2000. Outcome of the routine assessment of patients with intellectual disability in a genetics clinic. Am J Med Genet 90:60-68.
20. Hurtado MP, Swift EK, Corrigan JM, editors. 2001. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press.
21. Institute for Healthcare Improvement. 2003. The breakthrough series: IHI's Collaborative Model for Achieving Breakthrough Improvement. IHI Innovation Series White Paper. Institute for Healthcare Improvement, Boston (available on www.IHI.org , last accessed November 30, 2008).
22. Juran JM, editor. 1995. A history of managing for quality: The evolution, trends, and future directions of managing for quality. New York: McGraw-Hill.
23. Kilo CM. 1999. Improving care through collaboration. Pediatrics 103:384-393.
24. Kohn LT, Corrigan JM, Donaldson MS. 1999. To err is human: Building a safer health system. Washington, DC: National Academies Press.
25. Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJ, Goldenberg A, Saugier-Veber P, Pfundt R, Vissers LE, Destrée A, Grisart B, Rooms L, Van der Aa N, Field M, Hackett A, Bell K, Nowaczyk MJ, Mancini GM, Poddighe PJ, Schwartz CE, Rossi E, De Gregori M, Antonacci-Fulton LL, McLellan MD II, Garrett JM, Wiechert MA, Miner TL, Crosby S, Ciccone R, Willatt L, Rauch A, Zenker M, Aradhya S, Manning MA, Strom TM, Wagenstaller J, Krepischi-Santos AC, Vianna-Morgante AM, Rosenberg C, Price SM, Stewart H, Shaw-Smith C, Brunner HG, Wilkie AO, Veltman JA, Zuffardi O, Eichler EE, de Vries BB. 2008. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 45:710-720.
26. Lynn J, Baily MA, Bottrell M, Jennings B, Levine RJ, Davidoff F, Casarett D, Corrigan J, Fox E, Wynia MK, Agich GJ, O'Kane M, Speroff T, Schyve P, Batalden P, Tunis S, Berlinger N, Cronenwett L, Fitzmaurice JM, Dubler NN, James B. 2007. The ethics of using quality improvement methods in health care. Ann Intern Med 146:666-673.
27. Margolis PA, Lannon CM, Stuart JM, Fried BJ, Keyes-Elstein L, Moor DEJr, 2004. Practice based education to improve delivery systems for prevention in primary care: Randomized trial. Br Med J 328:388.
28. Mazmanian PE, Davis DA. 2002. Continuing medical education and the physician as a learner: Guide to the evidence. J Am Med Assoc 288:1057-1060.
29. Moeschler JB, Shevell MI, The AAP Committee on Genetics. 2006. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 117:2304-2316.
30. Moog U. 2005. The outcome of diagnostic studies on the etiology of mental retardation: Considerations on the classifications of causes. Am J Med Genet Part A 137A: 228-231.
31. Nelson EC, Batalden PB, Godfrey MM. 2007. Quality by design: A clinical microsystems approach. Chapter 14: The model for improvement. PDSA → SDSA. San Francisco, CA: Jossey-Bass. pp 271-283.
32. Nelson EC, Godfrey MM, Batalden PB, Berry SA, Bothe AE, McKinley KE, Melin CN, Muething SE, Moore LG, Wasson JH, Nolan TW. 2008. Clinical Microsystems. Part 1. The building blocks of health systems. Jt Comm J Qual Patient Saf 34:367-378.
33. Northern New England Cystic Fibrosis Consortium. 2009. last accessed January 2. www.nncfc.org.
34. Schechter MS, Margolis P. 2005. Improving subspecialty health care: Lessons from cystic fibrosis. J Pediatr 147:295-301.
35. Schuster MA, McGlynn EA, Brook RH. 1998. How good is the quality of health care in the United States? Millbank Q 76:517-563.
36. Somerville MJ, Mervis CB, Young EJ, Seo EJ, del Campo M, Bamforth S, Peregrine E, Loo W, Lilley M, Pérez-Jurado LA, Morris CA, Scherer SW, Osborne LR. 2005. Severe expressive-language delay related to duplication of the Williams-Beuren locus. N Engl J Med 353:1694-1701.
37. Tan TY, Aftimos S,Worgan L, Susman R, Wilson M, Ghedia S, Kirk EP, Love D, Ronan A, Darmanian A, Slavotinek A, Hogue J, Moeschler JB, Ozmore J, Widmer R, Savarirayan R, Peters G. 2009. Phenotypic expansion and further characterization of the 17q21.31 microdeletion syndrome. J Med Genet, May 15, 2009 [Epub ahead of print].
38. The Picker Institute and the American Hospital Association. 1996. Eye on patients. www.aha. org (last accessed May 29, 2009).
39. Van Karnebeek CDM, Jansweijer MCE, Leenders AGE, Offringa M, Hennekam RCM. 2005. A systematic literature review of 6 diagnostic investigations in individuals with intellectual disability. Eur J Hum Genet 13:6-15.
40. Varela MC, Simões-Sato AY, Kim CA, Bertola DR, De Castro CIE, Koiffmann CP. 2006. A new case of interstitial 6q16.2 deletion in a patient with Prader-Willi-like phenotype and investigation of SIM1 gene deletion in 87 patients with syndromic obesity. Eur J Med Genet 49: 298-305.
41. Wagner EH, Glasgow RE, Davis C, Bonomi AE, Provost L, McCulloch D, Carver P, Sixta C. 2001. Quality improvement in chronic illness care: A collaborative approach. Jt Comm J Qual Improv 27:63-80.
42. Wilson T, Berwick DM, Cleary PD. 2003. What do collaborative improvement projects do? Experience from seven countries. Jt Comm J Qual Saf 29:85-93.